Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/2007
03/07/2007EP1131414B1 Stable, attenuated rabies virus mutants and live vaccines thereof
03/07/2007EP1131348B1 Regulatory/unfolding peptides of ezrin
03/07/2007EP1061922B9 Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
03/07/2007EP1043998B1 USE OF PYRAZOLO [3,4-b] PYRIDINE AS CYCLIN DEPENDANT KINASE INHIBITORS
03/07/2007EP1032387B1 Novel metal complexes
03/07/2007CN1926130A Bis-indole pyrroles useful as antimicrobials agents
03/07/2007CN1926108A Non-nucleotide reverse transcriptase inhibitors
03/07/2007CN1925888A Identification of antigenically important neisseria antigens by screening insertional mutant libraries with antiserum
03/07/2007CN1925864A Plant-based medicament for the treatment of hepatitis c
03/07/2007CN1925863A Extracts of scutellaria for the treatment of sars
03/07/2007CN1923839A (9S)-Erythromycylamine water-soluble salt, preparation method and application thereof
03/07/2007CN1923812A New compounds
03/07/2007CN1923797A Pharmaceutical compounds
03/07/2007CN1923787A Eudesmane type sesquiterpenes acid and application thereof
03/07/2007CN1923289A Hybrid yeast avian influenza vaccine
03/07/2007CN1923288A Hybrid yeast influenza vaccine
03/07/2007CN1923285A Injectable sterile pharmaceutical formulation containing at least two active principles
03/07/2007CN1923279A Preparation method of newcastle disease-avian influenza combined emulsion vaccine
03/07/2007CN1923278A Mosaic vaccine of Ag85B and ESAT-6
03/07/2007CN1923273A Nose-plug medicine for treating common cold and its preparing process
03/07/2007CN1923269A Medicine for treating hepatitis B
03/07/2007CN1923267A External-use gynaecologic antibacterial drugs and its preparing method
03/07/2007CN1923264A Capsule comprising artemisia capillaries and rhizoma imperatae for treating hepatitis
03/07/2007CN1923243A Medicament for treating domestic animal bacteriosis and virosis and its preparation
03/07/2007CN1923237A Medicine for treating virus hepatitis B and its preparation method
03/07/2007CN1923235A Medicine for treating animal diarrhoea
03/07/2007CN1923233A Medicine for treating fowl bacterial diarrhea and its preparation method
03/07/2007CN1923209A Phthiobuzonum eye drops containing sodium hyaluronate and its preparing process
03/07/2007CN1923202A Use of chloride 13-hexyl berberine and chloride 13-hexyl palmatine in preparation of medicine for treating skin mucosa herpes viral infection
03/07/2007CN1923201A Use of chloride 13-hexyl berberine in preparation of medicine for treating peptic ulcer and bacteriological gastroenteritis
03/07/2007CN1923200A Use of chloride 13-hexyl berberine and chloride 13-hexyl palmatine in preparation of medicine for treating vagina and oral cavity infection-inflammation
03/07/2007CN1923188A Medical use of 2 alpha, 3 beta-dihydroxy-5, 11(13)- diallyl eudesmane-12 acid for inhibiting hepatitis B virus
03/07/2007CN1923183A Clarithromycin enteric medicinal composition
03/07/2007CN1923178A Oleanolic acid liposome preparation, freeze dried powder injecta thereof and its preparation
03/07/2007CN1923176A Oil-in-water baicalin nano-milk oral liquid and its preparing process
03/07/2007CN1923170A Imiquimod turbid liquor and gelling agent thereof
03/07/2007CN1303101C Small peptide sequence of combined site between envelope protein E2 of close hepatitis C virus and human CD81
03/07/2007CN1303089C Crystalline form of Adefovir dipivoxil and preparing process thereof
03/07/2007CN1303086C Compound of dual functional esterified prodrug of Cefetamet, and oral preparation
03/07/2007CN1303073C Substituted triazolone benzyl amine triazole antifungal compounds and method for preparing same
03/07/2007CN1303072C 7-oxo pyridopyrimidines
03/07/2007CN1303067C Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases
03/07/2007CN1302811C Externally-applicated chewing gum including chip-like center
03/07/2007CN1302809C Nanometer granule prepn of bufanin albumin and its prepn process
03/07/2007CN1302802C Baicaoganfukang medicine for treating hepatophathy
03/07/2007CN1302799C Oral Chinese medicinal composition for treating virus myocarditis
03/07/2007CN1302785C Health-care medicinal composition, and preparing method and use thereof
03/07/2007CN1302779C Pharmaceutical preparation comprising abacavir and alovudine and use thereof
03/07/2007CN1302776C Peptide arginals and methods for treating disseminated intravascular coagulation
03/06/2007US7186843 Aminomethylpyrrolidine derivatives having aromatic substituents
03/06/2007US7186841 Antiinflammation agents
03/06/2007US7186838 Fluorinated 4-azasteroid derivatives as androgen receptor modulators
03/06/2007US7186830 Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitors
03/06/2007US7186826 Phosphorus-containing compounds and uses thereof
03/06/2007US7186825 Polyamines for treatment of diseases such as cancer or treatment of tumors
03/06/2007US7186810 Modified peptides as therapeutic agents
03/06/2007US7186809 Methods and compositions relating to anti-interleukin-4 receptor antibodies
03/06/2007US7186803 Human vanilloid receptor VR3 protein
03/06/2007US7186753 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents
03/06/2007US7186752 Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
03/06/2007US7186739 O-succinimidyl-2-[(9H-fluoren-9-ylmethoxy)carbonylamino]-ethylcarbamate's used as monomers active in the synthesis of di- and tri-substituted ureas and urea oligomers
03/06/2007US7186738 antibiotics such as (5R)-3-[3-Fluoro-4-(3-methylisoxazol-5-yl)phenyl]-5-(1H-1,2,3-triazol-1-ylmethyl)-1,3-oxazolidin-2-one, having effective activity against both grampositive and gramnegative pathogens
03/06/2007US7186737 Inhibitors of p38
03/06/2007US7186736 Non-nucleoside reverse transcriptase inhibitors; N-[2-(2,5-dimethoxyphenylethyl)]-N'-2-(5-bromopyridyl)]-thiourea and N-[2-(2-fluorophenylethyl)]-N'-[2(5-bromopyridyl)]-thiourea; DDE236 or DDE240 respectively; inhibits virus replication; potency against HIV RT wild-type and drug-resistant mutants
03/06/2007US7186734 Binding to antagonist or inverse antagonist as antiinflammatory agentsand immunological disorders
03/06/2007US7186730 Bicyclic nitrogen-containing heterocyclic derivatives for use as antibacterials
03/06/2007US7186725 Anti-inflammatory compositions and methods
03/06/2007US7186720 Moderator of tumor necrosis factor; antiinflammatory agents; autoimmune diseases
03/06/2007US7186719 Antibacterial agents
03/06/2007US7186718 For therapy of autoimmune, inflammatory, proliferative and hyperproliferative diseases and immunologically-mediated diseases including rejection of transplanted organs or tissues and Acquired Immunodeficiency Syndrome (AIDS
03/06/2007US7186714 administering drugs such as 3-[2-(Cyclopentylamino)-4-pyrimidinyl]-2-(4-fluorophenyl)imidazo[1,2-a]pyridin-8-amine, for therapy of viral diseases caused by DNA viruses
03/06/2007US7186710 PDE4/7 inhibitors useful in treatment of airway disorders, autoimmune system disorders, skin disorders, arthritis, nerve system disorders
03/06/2007US7186708 Steroidal compounds
03/06/2007US7186703 Derivatives of branched-chain lipophilic molecules and uses thereof
03/06/2007US7186700 Administering a beta -L-2'-deoxynucleoside or its pharmaceutically acceptable salt, ester or prodrug therapy of a host infected with a drug-resistant form of HBV that exhibits a mutation at the 552 codon from methionine to valine in the DNA polymerase region
03/06/2007US7186545 Probiotic strains from Lactobacillus salivarius and antimicrobial agents obtained therefrom
03/06/2007US7186503 Compounds and methods for modulating activation of NF-κB
03/06/2007US7186412 Fusion proteins of Mycobacterium tuberculosis
03/06/2007US7186411 Vaccines absorbable by the transmucosal way
03/06/2007US7186410 Method for preparing human immunoglobulin concentrates for therapeutic use
03/06/2007CA2320488C Strategically modified hepatitis b core proteins and their derivatives
03/06/2007CA2219132C Nucleosides with anti-hepatitis b virus activity
03/06/2007CA2189131C Use of pteridine derivatives as no-synthase inhibitors
03/06/2007CA2141670C Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus
03/06/2007CA2132833C Hepatitis vaccines containing 3-o-deacylated monophosphoryl lipid a
03/02/2007CA2554859A1 A process for preparing an injectable sterile pharmaceutical formulation containing at least piperacillin sodium and tazobactam sodium active principles
03/01/2007WO2007025098A2 Triazole compounds and methods of making and using the same
03/01/2007WO2007025089A2 Triazole compounds and methods of making and using the same
03/01/2007WO2007024029A1 Antiviral agent and viral replication inhibitor
03/01/2007WO2007023912A1 Bifidobacterium having effect of inhibiting the adhesion of pathogenic microbes to cells, processed product thereof and food and medicinal composition containing the same
03/01/2007WO2007023880A1 Chemokine production inhibitor
03/01/2007WO2007023815A1 Therapeutic drug for heart disease and virus disease
03/01/2007WO2007023782A1 Neutralizing antibody directed against killer toxin-like protein, and use thereof
03/01/2007WO2007023507A2 Oxazolidinones bearing antimicrobial activity composition and methods of preparation
03/01/2007WO2007023381A1 Methods for the preparation of hcv polymerase inhibitors
03/01/2007WO2007023163A1 Polypeptides having antimicrobial activity and polynucleotides encoding same
03/01/2007WO2007022557A1 Mimotopes of epstein-barr virus (ebv) epitopes
03/01/2007WO2006138265A3 Heterocyclic aspartyl protease inhibitors, preparation and use thereof
03/01/2007WO2006130217A3 Substituted phosphate esters of nucleoside phosphonates
03/01/2007WO2006125121A3 Antimicrobial composition comprising a cationic surfacant and an iodinated sulpone compound
1 ... 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 ... 1798